The drug administration of China's Guangdong Province granted a medical device registration certificate to Shenzhen New Industries Biomedical Engineering's (SHE:300832) antiphospholipid antibody IgA assay kit (magnetic microparticle chemiluminescence method), according to a Wednesday disclosure on the Shenzhen Stock Exchange.
The certificate is valid until Aug. 5, 2029, the Chinese biomedical technology company said.
Shares of the company slipped less than 2% in recent trade.
Price (RMB): ¥62.48, Change: ¥-0.86, Percent Change: -1.36%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments